SION

Sionna Therapeutics, Inc. SION

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-29.89M

Quarter to Jun 30

Free cash flow

$-22.22M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$2.11B total
RA CAPITAL MANAGEMENT, L.P.
$435.72M0.0%
TPG GP A, LLC
$285.71M0.0%
VIKING GLOBAL INVESTORS LP
$140.56M0.0%
Atlas Venture Life Science Advisors, LLC
$131.78M0.0%
ORBIMED ADVISORS LLC
$112.43M-27.6%
Enavate Sciences GP, LLC
$109.01M0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$70.38M+966.7%
BlackRock, Inc.
$64.88M+13.8%
JPMORGAN CHASE & CO
$64.09M+1.7%
JENNISON ASSOCIATES LLC
$51.56M-19.2%
CITADEL ADVISORS LLC
$50.48M-1.7%
VANGUARD CAPITAL MANAGEMENT LLC
$49.80M+10.0%
STATE STREET CORP
$44.94M+35.1%
PERCEPTIVE ADVISORS LLC
$39.81M+37.4%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$29.95M-29.8%
Siren, L.L.C.
$26.86M+103.5%
PRICE T ROWE ASSOCIATES INC /MD/
$21.03M-36.8%
EVENTIDE ASSET MANAGEMENT, LLC
$20.89M-26.4%
GEODE CAPITAL MANAGEMENT, LLC
$20.11M+17.3%
BAKER BROS. ADVISORS LP
$17.60M0.0%
Casdin Capital, LLC
$17.60MNew
GOLDMAN SACHS GROUP INC
$17.10M+47.7%
DRIEHAUS CAPITAL MANAGEMENT LLC
$16.96M+403.0%
FRANKLIN RESOURCES INC
$12.76M+65.3%
abrdn plc
$12.50M-49.6%
See all 147 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SION

Earnings Per Share

13fpro.ai/company/SION

Loading ratio trend…

SION insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Sionna Therapeutics, Inc. (SION): stock profile, AI score and financials

Sionna Therapeutics, Inc. (SION) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SION is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Sionna Therapeutics, Inc. reports net income of $-29.9M, free cash flow of $-22.2M. Top institutional holders of SION by reported 13-F value include RA CAPITAL MANAGEMENT, L.P., TPG GP A, VIKING GLOBAL INVESTORS, based on the most recent SEC filings. SION trades on the Nasdaq exchange and files with the SEC under CIK 2036042. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SION daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sionna Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2036042 →